Otis Worldwide OTIS
Industrials · Industrial - Machinery · Synthos Deep Dive · 2026-07-03
The Overview
Otis makes and, more importantly, services elevators and escalators. The clever part: once an Otis elevator is installed, Otis gets paid every year to maintain it — and it maintains about 2.5 million units worldwide. That maintenance business is roughly two-thirds of sales, it recurs like a subscription, and it is the reason the company earns very high returns on the money it puts to work.
Is the stock cheap or expensive? Fairly priced, leaning slightly cheap. You pay about 17–18× next year's earnings for a steady, boring, cash-generative business. The stock has actually fallen ~27% over the past year while the market rose, mostly because its China new-installation business is shrinking and its service profit margins have been squeezed by higher labor costs.
Our verdict is Watch: a good company, an okay price, but nothing pulling it higher right now, plus it carries more debt than you'd like.
Here's what our three scores mean in everyday terms:
- Downside Risk 5/10 (middle of the road). The stock is defensive and doesn't swing wildly, but the company carries meaningful debt and the trend is down — so it's not "safe," just not fragile.
- Growth Quality 6/10 (good, not great). The recurring service business is excellent, but the whole company only grows in the mid-single digits.
- Exponential Potential 2/10 (low). Elevators are a mature, slow-growth market. This will never double overnight — it's a tortoise, not a rocket.
The one big worry: the profitable service business is getting squeezed by rising labor and material costs at the same time that Otis's China new-installation business is falling off a cliff. If both keep sliding, the "quality" thesis weakens.
Putting a number on it: our fair-value estimate is $82 against a current price of $71.74 — real upside if our numbers are right.
Our summary metrics
Beta 0.89 & a sticky service annuity, but net-debt/EBITDA ~3.0×, negative equity, China erosion, and a live downtrend (−27% 12-mo).
65% recurring service revenue and ~46% ROIC, but only ~6% revenue / ~12% EPS CAGR and service margins are compressing.
Low-single-digit organic growth, decelerating New Equipment, mature category — a quality compounder, not an exponential.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Low-single-digit organic growth, decelerating New Equipment, mature category — a quality compounder, not an exponential.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $93 (high $105 / low $77; median $97; 5 Buy · 7 Hold · 1 Sell — "Hold") — context, not our anchor |
| Valuation | 19× trailing EPS · 17.5× FY26E · 15.5× FY27E · 10.4× FY30E · EV/S 2.4× · EV/EBITDA 14.6× |
| Technicals | Downtrend — $73, −28% off 52-wk high, below the 200-DMA, RSI 61, −27% 12-mo vs SPY +21% |
| Conviction | Low — 0 expert voices in the Synthos KB; this is a quant/fundamentals call, transparently |
| Position sizing | If owned, a small ~1–2% income/quality sleeve — not a flagship conviction position |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for OTIS — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $71.74, 1% below the 50-day average ($73), 11% below the 200-day average ($80) — a downtrend. 23% below the 52-week high of $94, 3% above the 52-week low of $69.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $71.74 is currently inside the band (band $70–$74).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 48.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.06, negative momentum.
Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago
Solid = OTIS · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
Otis Worldwide (NYSE: OTIS) is the world's largest elevator and escalator company, founded in 1853, spun out of United Technologies/Raytheon in April 2020. It moves ~2.5 billion people a day and maintains the industry's largest service portfolio — ~2.5 million units — with ~45,000 field professionals across ~1,400 branches. Fiscal year ends December 31. CEO: Judith (Judy) Marks.
The business is a classic razor-and-blades: sell a New Equipment unit at thin margin, then earn a high-margin, recurring maintenance/repair/modernization annuity on it for decades.
Revenue mix (FY2025, from filings):
- By segment: Service $9.44B (65%) · New Equipment $4.99B (35%). The mix has been shifting toward Service — New Equipment fell from $5.81B (FY23) to $4.99B (FY25) as China collapsed, while Service grew from $8.40B to $9.44B. This mix shift is a quality upgrade even as headline growth stalls.
- By geography: Other (rest-of-world) $8.59B (60%) · United States $4.19B (29%) · China $1.65B (11%). The China line is the story: it fell from $2.88B (FY21) to $1.65B (FY25), −43% as Chinese property construction imploded.
Segment profitability tells the tension plainly: in Q1'26, Service operating margin 23.0% (down 160 bps YoY) vs New Equipment 3.3% (down 240 bps). Service is the profit engine; New Equipment is a low-margin lead-generator that is currently shrinking.
2. The expert thesis — why the panel is bullish (traceable)
There is no expert coverage of OTIS in the Synthos knowledge base — total_claims = 0, net-bullish voices = 0. No investor, podcast, or analyst voice in our distilled panel has made a traceable claim on this name.
Per Synthos house standard, we say that plainly rather than manufacture conviction. This verdict is entirely fundamentals- and quant-driven (financial statements, live analyst estimates, technicals, and management's own SEC-filed guidance). Nothing below rests on borrowed conviction, and there are no claim_ids to cite because none exist. Treat the absence of expert coverage as its own signal: OTIS is a well-understood, slow-moving industrial that the high-conviction growth voices in our KB simply do not talk about.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 5 · Moderate | Beta 0.89 and a sticky service annuity cushion the downside, but net-debt/EBITDA ~3.0×, negative book equity (buyback-driven), −43% China erosion, and a live downtrend (−27% 12-mo) keep this from being "safe." |
| Growth Quality | 6 · Good | ~65% recurring service revenue, ~46% ROIC, ~30% gross margin — a genuinely high-quality model. Capped at 6 because revenue grows only ~6% and service margins are actively compressing (labor/material cost). |
| Exponential Potential | 2 · Low | Low-single-digit organic growth, New Equipment declining, a mature global installed base. A quality compounder, structurally not an exponential. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | China stabilizes, service margins re-expand as pricing catches cost, WeMaintain/AI service tools lift retention. FY27E EPS beats to ~$4.90 (vs $4.72 cons); multiple re-rates to ~20× as growth credibility returns. | ~$98 (+34%) |
| Base (our anchor) | Estimates roughly hit — FY27E adj EPS ~$4.72; a 65%-recurring, ~12% EPS compounder with a service moat earns a ~17.5× multiple. | ~$82 (+12%) |
| Bear | China New Equipment keeps sliding, service margin compression persists, tariffs/Middle-East shipment delays bite. FY27E EPS misses to ~$4.30; multiple de-rates to ~14.5×. | ~$63 (−14%) |
Synthos fair value = the base case, ~$82 (+12%), with the full $63–$98 span as the honest range. Our base sits below the Street's $93 consensus — we give less credit to the FY27+ EPS ramp given the visible margin pressure, and we take the China/tariff drag seriously. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). OTIS is a quality compounder with essentially no exponential characteristics:
- Forward growth: revenue CAGR FY25→FY30E ~6.4% ($14.4B → $19.6B); adjusted EPS CAGR ~12% ($4.18 FY26E → $5.88 FY29E), the EPS growth out-running revenue thanks to buybacks, mix shift to service, and modest margin recovery.
- Acceleration (the 2nd derivative) is flat-to-negative: FY25 organic sales grew ~1–2%; New Equipment orders are up just 1% at constant currency while backlog quality is masked by a −20%+ China decline. There is no inflection here — this is a mature category growing with GDP + installed-base modernization.
- Room to run: the elevator TAM is large but not underpenetrated for a $28B incumbent; Otis already maintains the industry's largest portfolio. Modernization (upgrading aging units) is the one genuine multi-year tailwind — modernization backlog was +30% at constant currency in Q1'26 — but it lifts growth to mid-single digits, not double digits.
- Reinvestment runway: capex is light (~1% of revenue); the company returns cash via buybacks and a growing dividend rather than reinvesting for hyper-growth. That is appropriate for the model but is the opposite of an exponential profile.
Exponential Potential: Low (2/10). Own OTIS, if at all, for a defensive recurring-revenue annuity and dividend growth — never for a multibagger. Honest framing: this is a bond-like industrial, not a Degen-tier name.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $14.43B, +1.2% (FY24 $14.26B, FY23 $14.21B). Essentially flat at the top line for three years — service growth offset by New Equipment / China decline.
- Quarterly trajectory: Q1'25 $3.35B → Q2 $3.60B → Q3 $3.69B → Q4 $3.80B → Q1'26 $3.57B (+6% YoY reported, ~1% organic). Growth is real but low and FX/backlog-timing dependent.
- Margins: gross 30.4% TTM, EBIT ~15.4%, net 10.1% TTM. The tension is inside Service: Q1'26 service margin 23.0% (−160 bps) as labor/material cost and growth investments outran pricing — management's headline concern.
- Earnings: GAAP net income $1.38B FY25, GAAP EPS $3.50; adjusted EPS ~$4.00. Note the GAAP-vs-adjusted gap (restructuring/UpLift/separation items) — we anchor valuation on adjusted EPS, consistent with the estimate line.
- Cash flow: operating CF $1.60B, capex only −$152M, FCF ~$1.44B FY25 (FCF yield ~5.1%). High cash conversion is the model's best feature; it funds ~$0.8B buyback + ~$0.65B dividend.
- Balance sheet (the caveat): total debt $8.75B, net debt $7.65B, net-debt/EBITDA ~3.0–3.3× — elevated for an industrial. Book equity is negative (−$5.4B), a cosmetic artifact of post-spin buybacks (treasury stock + accumulated deficit), not distress — but it means ROE and P/B are meaningless here, and it removes balance-sheet cushion. Interest coverage ~10.8× is comfortable; the leverage is a discipline flag, not a solvency flag.
6. Valuation — priced in or room?
OTIS trades at 19× trailing / 17.5× FY26E / 15.5× FY27E adjusted EPS, EV/EBITDA 14.6×, EV/sales 2.4×, FCF yield ~5.1%, dividend yield ~2.3%. For a business with ~65% recurring revenue and ~46% ROIC, a high-teens forward multiple is reasonable-to-slightly-cheap — the market is not paying up here, which is the whole point of the setup. The de-rating (stock −27% over 12 months while EPS estimates held) has done the work.
The bull case is simply mean-reversion: if service margins recover and China stops bleeding, a mid-teens multiple on a ~12% EPS compounder is too low and the stock re-rates toward 20×. The bear case is that margin compression + China is structural, not cyclical, and the multiple stays low or drifts lower. On a reverse read, today's ~$73 implies the market expects roughly the low-single-digit organic growth Otis is actually printing — i.e. fairly priced for reality, with modest upside if execution improves. Street targets (context): consensus $93, high $105, low $77, median $97, rating "Hold." Our $82 base is deliberately below consensus because we weight the visible margin pressure more heavily. Not a value trap, not a bargain — a fairly-valued quality industrial waiting for a catalyst.
7. Technicals (from the tech block)
- Trend: down. $73.14 sits at the 50-DMA ($73.13) but well below the 200-DMA ($84.13) — a bearish posture (price under a falling 200-day).
- Location: −27.6% off the 52-week high ($101.07), only +5.5% off the 52-week low ($69.34) — near the lows, not the highs. Max drawdown from peak −31%.
- Momentum: RSI(14) 61 — neutral-to-firm, a bounce off oversold, not overbought. MACD roughly flat (−0.09).
- Relative strength (the tell): OTIS −27.2% 12-mo vs SPY +20.6% and QQQ +30.3%; −5.6% 3-mo vs SPY +13.7%. Persistent, heavy underperformance of both the market and growth — the opposite of a leadership name.
- Read: technicals do not confirm a buy. A defensive name in a firm tape shouldn't be down 27%; the chart is telling you the China/margin worry is live. If the fundamentals stabilize, the reclaim of the 200-DMA (~$84) would be the technical all-clear. Until then, the trend argues for patience — a reason the verdict is Watch.
8. Moat & competitive position
Otis's moat is the service annuity: an installed base of ~2.5M units generates recurring, high-margin maintenance and modernization revenue with ~90%+ retention, and switching costs (safety, code compliance, familiarity) are real. New Equipment is a low-margin razor whose value is placing blades (service contracts) into the field. This is a durable, GDP-plus model — the reason ROIC runs ~46% despite pedestrian growth. The vulnerabilities: China (both New Equipment demand and a competitive local market with players like KONE-type and domestic OEMs), service margin (a labor-cost business, hence the current squeeze), and modernization competition where independents can service others' units too. The WeMaintain majority investment (AI-enabled, digitally-native service) is a defensive move to protect the service moat against tech-forward disruptors — sensible, small.
Peer set (market cap, from FMP — note these are broad-industrial comps, not pure elevator peers): AMETEK $53.8B, Dover $28.8B, EMCOR $34.5B, Comfort Systems $61.3B, Ingersoll Rand $31.5B, Rockwell Automation $52.5B, Roper $36.8B, Wabtec $44.5B, Xylem $28.1B, Delta Air Lines $60.9B. Against this quality-industrial group OTIS is mid-cap and lower-growth; its distinguishing feature is the recurring-service mix, not its growth rate. (The true direct comps — KONE, Schindler, TK Elevator — are European/private and not in the FMP peer list.)
9. Management, capital allocation & guidance
- Capital allocation: shareholder-return focused — ~$0.8B buyback + ~$0.65B dividend in FY25 against ~$1.44B FCF, light capex (~1% of sales). Dividend ($1.70/yr, ~2.3% yield, ~44% payout) has room to grow. The flip side: buying back stock while carrying ~3× net leverage and negative equity is aggressive; it juices EPS but leaves no balance-sheet cushion. Disciplined, but leaning on leverage.
- Insider activity: the sampled window (May–June 2026) is routine director deferred-stock-unit awards and one officer RSU vesting/tax withholding (President, Otis Americas) — no discretionary open-market selling or buying cluster, nothing to read into.
- Management's own guidance (half-weighted — self-interested): the SEC 8-K earnings release (Q1'26, filed 2026-04-22) gives dated FY2026 outlook that management revised: net sales $15.1–$15.3B, organic sales up low-to-mid single digits (New Equipment down low-single-digits to flat, Service up mid-to-high single digits), adjusted operating profit ~$2.5B, adjusted EPS $4.20–$4.24, and adjusted free cash flow $1.60–$1.65B. CEO Judy Marks explicitly flagged "near-term pressures... in our Service margins from cost headwinds and investments in growth" and framed "decisive actions... on operational execution, pricing, and cost efficiency" — i.e. management concedes the margin problem and is guiding to fix it. Treat as management's own book: the EPS guide ($4.20–$4.24) essentially brackets the FY26E consensus ($4.18), so consensus is not running ahead of the company.
10. Catalysts & what to watch
- Next earnings: 2026-07-22 (Q2'26; Street EPS $1.01, revenue ~$3.75B). The line that matters: Service operating margin — does it stop compressing? And China New-Equipment trajectory.
- Service margin inflection: the single most important tell. Q1'26 was 23.0% (−160 bps). Pricing catching cost = the bull; continued compression = the bear.
- China stabilization: New Equipment orders/backlog in China and Asia-Pacific — the −20%+ declines need to flatten.
- Modernization backlog conversion: +30% CFX backlog is a real tailwind if it converts to revenue at decent margin.
- Capital returns: buyback pace and any dividend increase.
Thesis tripwires (what would change the call): two more quarters of service-margin compression (would cut Growth Quality toward 4 and push toward Avoid); China New Equipment stabilizing + service margin re-expanding (would upgrade toward Buy — Tactical); adjusted EPS guide cut below ~$4.10.
11. Key risks
- Service margin compression (the live risk): labor and material cost outrunning pricing — management's own flagged headwind; hits the profit engine directly.
- China structural decline: China revenue −43% since FY21 (to $1.65B); New Equipment down >20%. If Chinese property stays depressed, this is a permanent drag, not a cycle.
- Leverage / negative equity: net-debt/EBITDA ~3.0×, negative book equity, aggressive buyback — no balance-sheet cushion if EBITDA slips or rates on refinancing rise.
- Tariffs & geopolitics: the Q1'26 release cited tariff impacts and Middle-East shipment delays hitting New Equipment/modernization timing.
- Low growth / opportunity cost: even in the base case this is a ~6% top-line, ~12% EPS story — modest absolute return, and the chart shows the market has been unwilling to pay for it.
- No expert coverage: zero KB conviction means this call carries no independent-voice corroboration — it stands or falls on the fundamentals and quant read alone.
12. Verdict, position sizing & monitoring
Watch. Otis is a genuinely high-quality, recurring-revenue business trading at a fair-to-slightly-cheap price after a 27% de-rating — but it is a low-growth, China-exposed, leveraged compounder with actively compressing service margins and a live downtrend, and it carries zero expert conviction in the Synthos KB. The upside to our $82 base case (+12%) is real but modest, and the bear case ($63, −14%) is close enough to matter. There is no catalyst in hand and the price action is against it. That combination is the textbook definition of Watch: put it on the list, wait for the service-margin inflection, and let the chart reclaim the 200-DMA before paying up.
- Sizing: if owned for the dividend/quality, keep it small (~1–2%), income-sleeve, not a flagship conviction position. Not a buy here at Synthos-conviction size.
- Upgrade trigger: service margin re-expanding for two quarters + China New-Equipment stabilizing → revisit as Buy — Tactical. Downgrade trigger: guide cut or continued margin erosion → toward Avoid.
- Monitoring: re-score each earnings print; the 2026-07-22 Q2 report is the next read.
- Single biggest risk: service-margin compression colliding with China New-Equipment decline — the two together would break the "quality compounder" thesis.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — there is no expert coverage of OTIS in the Synthos knowledge base, stated plainly. This verdict is fundamentals- and quant-driven; no conviction is borrowed and no
claim_ids are cited because none exist. Fabricated conviction is structurally impossible (claim-ID reconciliation). - Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from SEC 8-K filed 2026-04-22. Forward figures are analyst consensus (FMP) or management guidance, each labeled as estimates.
- Management caveat: the FY2026 outlook in §9 is management's own SEC-filed guidance — self-interested, half-weighted by design.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").